Covestor’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6K Hold
282
– – ﹤0.01% 1778
2026
Q2
$10K Buy
282
+41
+17% +$1.4K 0.01% 1570
2026
Q1
$8K Sell
241
-12
-5% -$508 0.01% 1543
2025
Q4
$11K Sell
253
-9
-3% -$377 0.01% 1514
2025
Q3
$9K Sell
262
-177
-40% -$6.15K 0.01% 1644
2025
Q2
$13K Buy
439
+39
+10% +$1.11K 0.01% 1399
2025
Q1
$12K Buy
400
+5
+1% +$153 0.01% 1386
2024
Q4
$11K Buy
395
+22
+6% +$728 0.01% 1466
2024
Q3
$14K Buy
373
+19
+5% +$678 0.01% 1354
2024
Q2
$11K Buy
354
+13
+4% +$451 0.01% 1453
2024
Q1
$13K Sell
341
-38
-10% -$1.33K 0.01% 1375
2023
Q4
$12K Buy
379
+53
+16% +$1.33K 0.01% 1416
2023
Q3
$8K Buy
326
+19
+6% +$433 0.01% 1531
2023
Q2
$6K Buy
307
+264
+614% +$5.99K ﹤0.01% 1671
2023
Q1
$1K Sell
43
-92
-68% -$2.44K ﹤0.01% 1829
2022
Q4
$3K Sell
135
-120
-47% -$2.42K ﹤0.01% 1681
2022
Q3
$4K Buy
255
+249
+4,150% +$4.39K ﹤0.01% 1534
2022
Q2
$0 Sell
6
-26
-81% -$437 ﹤0.01% 1969
2022
Q1
$1K Sell
32
-2
-6% -$38 ﹤0.01% 1761
2021
Q4
$1K Buy
+34
New +$663 ﹤0.01% 1689

Other funds holding COLL

Covestor's COLL Position: Q3 2026 in Review

Covestor held its Collegium Pharmaceutical (COLL) position steady in Q3 2026 at 282 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #1778.

Covestor first reported a position in COLL in Q4 2021 and has held it in 20 quarters since. The position peaked at $14K in Q3 2024. 185 funds tracked by Wall St. Rank hold COLL as of Q3 2026.

  • Covestor held 282 shares of Collegium Pharmaceutical worth $6K as of Q3 2026.
  • Covestor left its Collegium Pharmaceutical share count unchanged in Q3 2026.
  • Collegium Pharmaceutical made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #1778 holding.
  • Covestor first reported a position in Collegium Pharmaceutical in Q4 2021 and has held it in 20 quarters since.
  • Covestor's Collegium Pharmaceutical position peaked at $14K in Q3 2024.
  • 185 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.